| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 08/29/2013 | US20130224854 Anti-single-chain type iv collagen polypeptide antibody, pharmaceutical drug, diagnostic, preventive, or therapeutic drug for tumour containing the antibody |
| 08/29/2013 | US20130224827 Endothelial nitric oxide synthase |
| 08/29/2013 | US20130224800 Enzymes Having Alpha Amylase Activity and Methods of Making and Using them |
| 08/29/2013 | US20130224769 Methods of using chemokine panec-1 antibodies |
| 08/29/2013 | US20130224759 Methods, devices, kits and compositions for detecting roundworm |
| 08/29/2013 | US20130224287 Liposome-Based Construct Comprising a Peptide Modified Through Hydrophobic Moieties |
| 08/29/2013 | US20130224234 Ttll4 peptides and vaccines containing the same |
| 08/29/2013 | US20130224226 Insect binding antibodies |
| 08/29/2013 | US20130224225 Antibodies and pharmaceutical compositions containing same useful for inhibiting activity of metalloproteins |
| 08/29/2013 | US20130224224 Cx3cr1-binding polypeptides |
| 08/29/2013 | US20130224220 ErbB3 BINDING ANTIBODY |
| 08/29/2013 | US20130224219 Drug and method for the prophylaxis of hiv infection and for the prophylaxis and treatment of diseases caused by or associated with hiv, including aids |
| 08/29/2013 | US20130224212 Methods and products relating to gsk3ss regulation |
| 08/29/2013 | US20130224211 Glycated cd59 peptides, their preparation, and uses thereof |
| 08/29/2013 | US20130224210 Antibodies to matrix metalloproteinase 9 |
| 08/29/2013 | US20130224207 Identification of antibodies specific for lyssaviruses and methods of their use |
| 08/29/2013 | US20130224206 Compositions and methods for stem cell delivery |
| 08/29/2013 | US20130224205 Multispecific deimmunized cd3-binders |
| 08/29/2013 | US20130224202 Single-chain variable fragment anti-cd133 antibodies and uses thereof |
| 08/29/2013 | US20130224201 Antibodies to il-6 and use thereof |
| 08/29/2013 | US20130224199 Viral chemokine-antigen fusion proteins |
| 08/29/2013 | US20130224191 Notum protein modulators and methods of use |
| 08/29/2013 | US20130224190 Anti-cd19 antibody having adcc and cdc functions and improved glycosylation profile |
| 08/29/2013 | US20130224189 Tweak receptor |
| 08/29/2013 | US20130224188 CD47 Antibodies and Methods of Use Thereof |
| 08/29/2013 | US20130224187 ANTI-C5a ANTIBODIES AND METHODS FOR USING THE ANTIBODIES |
| 08/29/2013 | US20130224185 Protein formulation |
| 08/29/2013 | US20130224174 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-trna synthetases |
| 08/29/2013 | US20130224116 Markers of Endothelial Progenitor Cells and Uses Thereof |
| 08/29/2013 | US20130224111 Inhibition Of CD69 For Treatment Of Inflammatory Conditions |
| 08/29/2013 | US20130224109 Compositions and methods featuring il-6 and il-21 antagonists |
| 08/29/2013 | US20130224108 Methods for the Treatment of Head and Neck Squamous Cell Carcinoma |
| 08/28/2013 | EP2631248A2 Treatment of tumors using specific anti-L1 antibody |
| 08/28/2013 | EP2631247A1 Means and methods of measuring parathyroid hormone in patients suffering from oxidative stress |
| 08/28/2013 | EP2631246A1 Monoclonal antibody having immunosuppressive activity or fragment to which antigen thereof is bonded |
| 08/28/2013 | EP2631245A1 Chimeric factor H binding proteins (fHBP) containing a heterologous B domain and methods of use |
| 08/28/2013 | EP2630970A1 Cytotoxic immunoglobulin |
| 08/28/2013 | EP2630242A1 Identification of antibodies specific for lyssaviruses and methods of their use |
| 08/28/2013 | EP2630162A2 Polyvalent chimeric ospc vaccinogen and diagnostic antigen |
| 08/28/2013 | EP2630161A1 Compositions, antibodies, asthma diagnosis methods, and methods for preparing antibodies |
| 08/28/2013 | EP2630160A1 Erbb3 binding antibody |
| 08/28/2013 | EP2630159A1 Stable and soluble antibodies |
| 08/28/2013 | EP2629798A2 Anti-folate receptor alpha antibody glycoforms |
| 08/28/2013 | EP2629796A2 Antibodies |
| 08/28/2013 | CN103270050A An immunosuppressive drug combination for a stable and long term engraftment |
| 08/28/2013 | CN103270049A Spider silk fusion protein structures for binding to an organic target |
| 08/28/2013 | CN103270047A Oprf/i agents and their use in hospitalized and other patients |
| 08/28/2013 | CN103270044A Support for affinity chromatography and method for isolating immunoglobulin |
| 08/28/2013 | CN103269718A Pharmaceutical formulation comprising a biopharmaceutical drug |
| 08/28/2013 | CN103266089A Anti-human copeptin monoclonal antibody mcco1 and application thereof |
| 08/28/2013 | CN103266088A H7 subtype avian influenza virus monoclonal antibody of and kit |
| 08/28/2013 | CN103265633A Saliva streptococcus urase antibody, and preparation method and applications thereof |
| 08/28/2013 | CN103265632A Method for obtaining polyclonal antibody of sheep-ras-related and estrogen-regulated growth inhibitor |
| 08/28/2013 | CN103265631A Heavy chain and light chain variable regions of anti-human CRT monoclonal antibody |
| 08/28/2013 | CN103265440A Method of detecting content of phenylethanolamine A and detection kit |
| 08/28/2013 | CN102660509B Monoclonal antibody of evodiamine derivative, preparation method and application thereof |
| 08/28/2013 | CN102250243B Antibody to interleukins-15 |
| 08/28/2013 | CN102206279B ScFv antibody for detection of enrofloxacin, its coding gene and application thereof |
| 08/28/2013 | CN102206254B Lysine decarboxylase epitope, anti-decarboxylase epitope antibody and application thereof |
| 08/28/2013 | CN102206251B Acyl carrier protein III epitope, acyl carrier protein III antibody and use thereof |
| 08/28/2013 | CN102199211B Method and special enzyme-linked immunoassay kit for detecting cowpea trypsin inhibitor |
| 08/28/2013 | CN102174107B Monoclonal antibody for plague bacillus Pla (plasminogen activator) and application thereof |
| 08/28/2013 | CN102046207B Drug fusions and conjugates |
| 08/28/2013 | CN101993491B Antibody combined with tubercle bacillus bacteriophage head protein as well as preparation method and application thereof |
| 08/27/2013 | US8519112 Humanized antibodies against monocyte chemotactic proteins |
| 08/27/2013 | US8519109 Tumour rejection antigens |
| 08/27/2013 | US8519107 IL-17A antibodies |
| 08/27/2013 | US8519105 Compositions and methods for treating kidney disease |
| 08/27/2013 | US8519104 Monoclonal antibodies against GMF-B antigens, and uses therefor |
| 08/27/2013 | US8518889 Method of treating cancer with antibodies against long-form leukotriene B4 receptor BLT2 |
| 08/27/2013 | US8518888 Method of treatment of gastrointestinal-type cancer with antagonistic antibodies to IL-11R |
| 08/27/2013 | US8518887 Method of treating cancer with DLL4 antagonist and chemotherapeutic agent |
| 08/27/2013 | US8518871 Skin permeating and cell entering (SPACE) peptides and methods of use thereof |
| 08/27/2013 | US8518695 Compositions comprising polynucleotides encoding RDCVF1 or RDCVF2 |
| 08/27/2013 | US8518657 Method of prognosing and diagnosing hereditary spastic paraplegia, mutant nucleic acid molecules and polypeptides |
| 08/27/2013 | US8518655 Means for the diagnosis and therapy of CTCL |
| 08/27/2013 | US8518653 Detection of cannabis use |
| 08/27/2013 | US8518652 Truncated proteins as cancer markers |
| 08/27/2013 | US8518641 DNA damage testing |
| 08/27/2013 | US8518436 Engineered extracellular matrices |
| 08/27/2013 | US8518407 Therapeutic human anti-IL-1R1 monoclonal antibody |
| 08/27/2013 | US8518406 Antibodies directed against pyroglutamate monocyte chemoattractant protein-1 (MCP-1 N1pE) |
| 08/27/2013 | US8518404 Activatable binding polypeptides and methods of identification and use thereof |
| 08/27/2013 | US8518105 Methods and apparatuses for coating a lesion |
| 08/27/2013 | CA2769433A1 Biomarkers for early determination of a critical or life threatening response to illness and monitoring response to treatment thereof |
| 08/27/2013 | CA2613818C Anti-il-23 antibodies, compositions, methods and uses |
| 08/27/2013 | CA2558371C Methods of modulating immune responses by modulating tim-1 and tim-4 function |
| 08/27/2013 | CA2508773C Canine rankl and methods for preparing and using the same |
| 08/27/2013 | CA2403425C Multivalent antibodies and uses therefor |
| 08/27/2013 | CA2400441C Nucleic acid molecule encoding a mismatch endonuclease and methods of use thereof |
| 08/27/2013 | CA2227301C Hcv binding protein |
| 08/22/2013 | WO2013123193A1 Pyruvate kinase m2 neutralizing antibodies for inhibiting angiogenesis |
| 08/22/2013 | WO2013123061A1 Bispecific chimeric antigen receptors and therapeutic uses thereof |
| 08/22/2013 | WO2013122544A2 IL-1β NEUTRALIZING HUMAN MONOCLONAL ANTIBODIES |
| 08/22/2013 | WO2013121296A1 Erythrocyte-binding therapeutics |
| 08/22/2013 | WO2013120973A1 Method of producing high-affinity antibodies |
| 08/22/2013 | WO2013120929A1 Fc-receptor based affinity chromatography |
| 08/22/2013 | WO2013120554A1 Antibodies that bind peptidoglycan recognition protein 1 |
| 08/22/2013 | WO2013120553A1 Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (trem-1) |
| 08/22/2013 | WO2013096380A3 Anti-phf-tau antibodies and their uses |